BioSpace News Archive

Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthroughs against otherwise undruggable disease-causing targets, today announced that Chris Varma, Ph.D., Frontier’s co-founder, chairman, and CEO, will present a company overview at the 40th Annual J.P. Morgan Healthcare Conference.

AbbVie (NYSE: ABBV) will announce its fourth-quarter and full-year 2021 financial results on Wednesday, February 2, 2022, before the market opens.

Blueprint Medicines Corporation announced that its Board of Directors has appointed Kate Haviland to succeed Jeff Albers as Chief Executive Officer, effective April 4, 2022.

Harmony Biosciences Holdings, Inc. today announced that Harmony’s President and CEO, John C. Jacobs will present a company update and host investor meetings at the upcoming 40th Annual J.P. Morgan Healthcare Conference.